Health
Oxford covid vaccine: AstraZeneca denies trial subject had nerve ailment – Mint
Trials of the Oxford-Astra vaccine resumed in the UK over the weekend, after a pause to investigate the adverse event, while researchers in South Africa also restarted tests.But a big US trial of the vaccine is still on hold
AstraZeneca Plc, the drugmaker working with the University of Oxford on a Covid-19 vaccine, contradicted a report that a volunteer in U.K. tests of the shot developed a rare nerve disease that might have signaled severe safety problems.AstraZeneca was responding Thursday to a CNN report citing documents indicating that the diagnosis of the participant was confirmed as transverse myelitis. The diagnosis was based on preliminary findings,” and is inaccurate, the Cambridge, England-based drugmaker …
-
Noosa News8 hours agoArnie the dog found dead in stolen ute after week of searching
-
Noosa News7 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car
-
Noosa News13 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News14 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane